1894
DOI: 10.1002/ardp.18942320302
|View full text |Cite
|
Sign up to set email alerts
|

Über Cytisin und Ulexin

Abstract: Dr. A. P a r t h e i 1, Ueber Cytisin und Ulexin. 161 Mitteilungen aus dem pharmaneutisch-ohemhehenInstitut der Universitat Marburg. 52. 8ber Cytisin und Ulexin. 11. Abhandlung.Ton Dr. A. P a r t h e i l . In einer friiheren Mitteilung *) habe ich die Identittlt des Cytisins mit dem Ulexin durch vergleichende Untersuchung der beiden Baaen, ihrer physikalischen Eigenschaften und einer Reihe von wohlcharakterisierlen Abkbmmlingen unzweifelhaft festgestellt und auch die bisher iiber diesen Gegenstand vorliegende … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1901
1901
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The nitration of cytisine was first reported in 1894, 16 and the isolation and characterization (but not the structure elucidation) of the title compound were described a few years later. 17 The latter procedure was followed in general terms in the present work.…”
Section: Experimental Synthesismentioning
confidence: 99%
“…The nitration of cytisine was first reported in 1894, 16 and the isolation and characterization (but not the structure elucidation) of the title compound were described a few years later. 17 The latter procedure was followed in general terms in the present work.…”
Section: Experimental Synthesismentioning
confidence: 99%
“…Preclinical studies with acetylcholine receptor ligands such as nicotine, epibatidine, and ABT-594 have pointed toward new therapies in analgesia, cognition, and the treatment of addiction . However, the nicotinic agent cytisine 1 , isolated from natural sources in 1894, has not garnered nearly as much attention. Heinemann et al recently demonstrated that cytisine behaves as a partial agonist at neuronal nicotinic receptors with an EC 50 = 1 μM.…”
mentioning
confidence: 99%
“…Cytisine 42 is a tricyclic quinolizidine alkaloid extracted from the seeds of Cytisus laburnum and other plants in the Leguminosae family. [68,69] It is a partial agonist to b-2 containing nicotinic acetylcholine receptors (nAChRs), which can influence the cognitive processes in humans. [70,71] Therefore, it has shown to be a potential therapeutic agent in the treatment of Alzheimer's, [72][73][74] Parkinson's diseases, [75] schizophrenia, [76,77] anxiety and depression.…”
Section: Desymmetrization Of 13-diol In the Synthesis Of Cytisine 42mentioning
confidence: 99%